Tineke J. Smilde

5.8k total citations
71 papers, 2.3k citations indexed

About

Tineke J. Smilde is a scholar working on Surgery, Oncology and Cancer Research. According to data from OpenAlex, Tineke J. Smilde has authored 71 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Surgery, 23 papers in Oncology and 21 papers in Cancer Research. Recurrent topics in Tineke J. Smilde's work include Lipoproteins and Cardiovascular Health (12 papers), Breast Cancer Treatment Studies (10 papers) and Cancer, Lipids, and Metabolism (9 papers). Tineke J. Smilde is often cited by papers focused on Lipoproteins and Cardiovascular Health (12 papers), Breast Cancer Treatment Studies (10 papers) and Cancer, Lipids, and Metabolism (9 papers). Tineke J. Smilde collaborates with scholars based in Netherlands, United States and France. Tineke J. Smilde's co-authors include Anton F. H. Stalenhoef, John J.P. Kastelein, Sanne van Wissen, Hub Wollersheim, Mieke D. Trip, J.W.M. van der Meer, Vivianne C. G. Tjan‐Heijnen, Maaike de Boer, Chantal P. Bleeker‐Rovers and Agnès J. van de Wouw and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Journal of the American College of Cardiology.

In The Last Decade

Tineke J. Smilde

66 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tineke J. Smilde Netherlands	25	631	629	524	419	319	71	2.3k
Laurel W. Rice United States	38	895 1.4×	1.0k 1.6×	454 0.9×	180 0.4×	373 1.2×	122	4.5k
Helgi Sigvaldason Iceland	32	688 1.1×	599 1.0×	374 0.7×	359 0.9×	391 1.2×	82	3.3k
Konstantinos P. Economopoulos United States	34	703 1.1×	1.6k 2.5×	869 1.7×	346 0.8×	821 2.6×	102	3.5k
Steven A. White United Kingdom	23	906 1.4×	1.2k 1.9×	537 1.0×	139 0.3×	246 0.8×	96	2.4k
Linda X. Jin United States	26	655 1.0×	908 1.4×	692 1.3×	137 0.3×	401 1.3×	60	2.6k
Aihua Bian United States	32	215 0.3×	385 0.6×	176 0.3×	202 0.5×	521 1.6×	86	2.8k
Carlton C. Barnett United States	39	621 1.0×	1.9k 3.1×	695 1.3×	290 0.7×	566 1.8×	108	4.9k
John‐Bjarne Hansen Norway	40	489 0.8×	777 1.2×	444 0.8×	217 0.5×	631 2.0×	194	4.5k
Sigrid K. Brækkan Norway	36	626 1.0×	738 1.2×	509 1.0×	153 0.4×	404 1.3×	167	4.6k
Ross C. Smith Australia	34	1.0k 1.7×	981 1.6×	630 1.2×	364 0.9×	475 1.5×	110	3.2k

Countries citing papers authored by Tineke J. Smilde

Since Specialization

Citations

This map shows the geographic impact of Tineke J. Smilde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tineke J. Smilde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tineke J. Smilde more than expected).

Fields of papers citing papers by Tineke J. Smilde

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tineke J. Smilde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tineke J. Smilde. The network helps show where Tineke J. Smilde may publish in the future.

Co-authorship network of co-authors of Tineke J. Smilde

This figure shows the co-authorship network connecting the top 25 collaborators of Tineke J. Smilde. A scholar is included among the top collaborators of Tineke J. Smilde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tineke J. Smilde. Tineke J. Smilde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Richters, Anke, Heidi P. Fransen, Tineke J. Smilde, et al.. (2024). Guidelines versus real-world data in metastatic bladder cancer: A population-based study on first-line chemotherapy treatment patterns. Urologic Oncology Seminars and Original Investigations. 43(5). 328.e17–328.e24.

Brom, Linda, Arnold Baars, Jean‐Paul van Basten, et al.. (2024). Open communication between patients and relatives about illness & death in advanced cancer—results of the eQuiPe Study. Supportive Care in Cancer. 32(4). 214–214. 3 indexed citations

Fransen, Heidi P., Natasja Raijmakers, Ben van den Borne, et al.. (2023). Trajectories of emotional functioning and experienced care of relatives in the last year of life of patients with advanced cancer: A longitudinal analysis of the eQuiPe study. Psycho-Oncology. 32(12). 1858–1866. 2 indexed citations

Tolmeijer, Sofie H., Sandra van Wilpe, Maartje J. Geerlings, et al.. (2023). Early On-treatment Circulating Tumor DNA Measurements and Response to Immune Checkpoint Inhibitors in Advanced Urothelial Cancer. European Urology Oncology. 7(2). 282–291. 10 indexed citations

Bosch, D. Andries, Metin Tascilar, Tineke J. Smilde, et al.. (2023). Reliability and Efficiency of the CAPRI-3 Metastatic Prostate Cancer Registry Driven by Artificial Intelligence. Cancers. 15(15). 3808–3808. 3 indexed citations

Raijmakers, Natasja, Janneke van Roij, Anja Visser, et al.. (2021). Spiritual Well-Being and Associated Factors in Dutch Patients With Advanced Cancer. Journal of Pain and Symptom Management. 63(3). 404–414. 16 indexed citations

Wit, Ronald de, Simon Horenblas, Janine Nuver, et al.. (2020). Dose-Dependent Effect of Platinum-Based Chemotherapy on the Risk of Metachronous Contralateral Testicular Cancer. Journal of Clinical Oncology. 39(4). 319–327. 13 indexed citations

Wit, Ronald de, Jourik A. Gietema, Gerard Groenewegen, et al.. (2020). Incidence of metachronous contralateral testicular germ cell tumour and association with chemotherapy. European Urology Open Science. 19. e405–e406.

Krens, Stefanie D., Winette T.A. van der Graaf, Sasja F. Mulder, et al.. (2020). The relationship between sunitinib exposure and both efficacy and toxicity in real‐world patients with renal cell carcinoma and gastrointestinal stromal tumour. British Journal of Clinical Pharmacology. 87(2). 326–335. 22 indexed citations

10.

Oort, Inge M. van, Gerald W. Verhaegh, Onno van Hooij, et al.. (2020). Abstract 1413: Exploring the prognostic value of microRNAs and drug exposure in patients with metastatic castration resistant prostate cancer treated with abiraterone: a prospective observational study. Cancer Research. 80(16_Supplement). 1413–1413.

11.

Kampen, Roel J.W. van, Bram Ramaekers, D.J.A. Lobbezoo, et al.. (2017). Real-world and trial-based cost-effectiveness analysis of bevacizumab in HER2-negative metastatic breast cancer patients: a study of the Southeast Netherlands Breast Cancer Consortium. European Journal of Cancer. 79. 238–246. 12 indexed citations

12.

Kampen, Roel J.W. van, D.J.A. Lobbezoo, Maaike de Boer, et al.. (2017). A real-world study on implementation of bevacizumab in a cohort of HER2-negative metastatic breast cancer patients: A study of the Southeast Netherlands Breast Cancer Consortium. Cancer Treatment and Research Communications. 13. 3–8. 1 indexed citations

13.

Lobbezoo, D.J.A., Wilfred Truin, Adri C. Voogd, et al.. (2016). The role of histological subtype in hormone receptor positive metastatic breast cancer: similar survival but different therapeutic approaches. Oncotarget. 7(20). 29412–29419. 9 indexed citations

14.

Lobbezoo, D.J.A., Roel J.W. van Kampen, Adri C. Voogd, et al.. (2013). Prognosis of metastatic breast cancer subtypes: the hormone receptor/HER2-positive subtype is associated with the most favorable outcome. Breast Cancer Research and Treatment. 141(3). 507–514. 186 indexed citations

15.

Aarts, Maureen J.B., Frank Peters, Caroline M.P.W. Mandigers, et al.. (2013). Primary Granulocyte Colony-Stimulating Factor Prophylaxis During the First Two Cycles Only or Throughout All Chemotherapy Cycles in Patients With Breast Cancer at Risk for Febrile Neutropenia. Journal of Clinical Oncology. 31(34). 4290–4296. 38 indexed citations

16.

Bleeker‐Rovers, Chantal P., Fidel J. Vos, Elisabeth M. H. A. de Kleijn, et al.. (2007). A Prospective Multicenter Study on Fever of Unknown Origin. Medicine. 86(1). 26–38. 264 indexed citations

17.

Bont, Natasja de, Mihai G. Netea, Chantal P. Bleeker‐Rovers, et al.. (2006). LPS-Induced Release of IL-1 β , IL-1Ra, IL-6, and TNF- α in Whole Blood from Patients with Familial Hypercholesterolemia: No Effect of Cholesterol-Lowering Treatment. Journal of Interferon & Cytokine Research. 26(2). 101–107. 18 indexed citations

18.

Wissen, Sanne van, Tineke J. Smilde, Eric de Groot, et al.. (2003). The significance of femoral intima-media thickness and plaque scoring in the Atorvastatin versus Simvastatin on Atherosclerosis Progression (ASAP) study. European Journal of Cardiovascular Prevention & Rehabilitation. 10(6). 451–455. 18 indexed citations

19.

Berkmortel, Franchette W.P.J. van den, Tineke J. Smilde, Hub Wollersheim, et al.. (2000). Intima–media thickness of peripheral arteries in asymptomatic cigarette smokers. Atherosclerosis. 150(2). 397–401. 35 indexed citations

20.

Lemmink, Henny H., Lambert P.W.J. van den Heuvel, Gerard Merkx, et al.. (1996). Linkage of Gitelman syndrome to the thiazide-sensitive sodium-chloride cotransporter gene with identification of mutations in Dutch families. Pediatric Nephrology. 10(4). 403–407. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact